|Joy E. Anderson, M.D.
|Barbara Asselin, M.D.
|Clinical trials for multiple childhood cancers, specializing in leukemia & lymphoma
|Robert Bambara, Ph.D.
|Mechanisms of DNA replication, repair and recombination
|Richard K. Barth, Ph.D.
|Tumor immunology and virology
|Ravi Basavappa, Ph.D.
|Crystallography of proteins involved in cell cycle regulation
|Swati Basu, M.D.
|Coorelation between pediatric hodgkin’s disease and breast cancer
|Michael Becker, M.D.
|Stem cell research in hematology/oncology
|John M. Bennett, M.D.
|Clinical trials for multiple cancers
|William A. Bernhard, Ph.D.
|Effects of radiation on DNA
|Steven H. Bernstein, M.D.
|Development of novel immunotherapeutic approaches to the treatment of patients with lymphoproliferative disorders
|Neil Blumberg, M.D.
|Blood transfusion immunology
|Dirk Bohmann, Ph.D.
|Signals that enable cancer cells to grow
|William Bonnez, M.D.
|The papilloma virus and cervical cancer
|Andrea Bottaro, Ph.D.
|DNA sequences/how immune cells become cancerous
|William J. Bowers, Ph.D.
|Novel antigens that protect against cancer
|Ralph Brasacchio, M.D.
|Genitourinary Tumors; Brachytherapy
|Lauren Bruckner, M.D., Ph.D.
|Pediatrics bone marrow transplant
|Marc Brown, M.D.
|Clinical studies to treat basal cell carcinomaMicrosopically controlled surgery for cutaneous malignancies
|Chawnshang Chang, Ph.D.
|Molecular mechanisms of prostate cancer progression
|Yuhchyau Chen, M.D., Ph.D.
|Lung Tumors; Radiosensitization
|Louis S. (Sandy) Constine, M.D.
|Radiation oncology and use of MRI for detecting brain tumors for children
|Stephen Dewhurst, Ph.D.
|Cancer vaccine development
|Bruce M. Fenton, Ph.D.
|Tumor Oxygenation; Angiogenesis
|Richard I. Fisher, M.D.
|Overall direction of the Cancer Center and clinical trials for multiple cancers
|Susan Gross Fisher, Ph.D.
|Viral etiology of malignancy
Conduct and analysis of clinical trials
|Thomas Foster, M.D., Ph.D.
|Imaging methods to characterize tumor oxygenation and tumor environment
|John G. Frelinger, Ph.D.
|Jonathan Friedberg, M.D.
|Therapy for follicular lymphoma
|Patrick Fultz, M.D.
|Barry M. Goldstein, M.D., Ph.D.
|Basic enzyme mechanisms. Rational design of anti-tumor and antiviral drugs
|Mary J. Hauk, D.D.S.
|Salivary function in long term survivors of cancer
|Jeffrey Hayes, Ph.D.
|Jane T. Hickok, M.D.
|Cancer Therapeutic Control; Radiation Oncology
|Russell Hilf, Ph.D.
|How hormones effect tumor growthPhotodynamic therapy (PDT), for a variety of malignancies
|P. M. Hinkle, Ph.D.
|Molecular cell regulation
Keep tumors from developing resistance to chemotherapy
|Wei Hsu, Ph.D.
|Alissa Huston, M.D.
|Treatment of chemotherapy-induced osteoporosis in breast cancer patients
Mechanisms of cancer metastasizing to bone
|Jainulabdeen J. Ifthikharuddin, M.D.
|Clinical trials for Non-Hodgkin’s lymphoma, leukemia, and multiple myeloma
|Craig Jordan, Ph.D.
|A leader in leukemia and stem cell research
|Alan W. Katz, M.D. , M.P.H.
|Gastrointestinal Tumors; Brachytherapy
|Peter C. Keng, Ph.D.
|DNA repair and proteins regulating cell cycle
|Scott D. Kennedy, Ph.D.
|Magnetic resonance imaging
|Manish Kohli, M.D.
|Physician & researcher in urology oncology
|Alok Khorana, M.D.
|Replicating Viruses for Cancer Therapy
|Paul D. Kingsley, Ph.D.
|The mechanisms that initiate blood cell development
|Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
|David N. Korones, M.D.
|Peter LaCelle, Ph.D.
|Hematologic Disorders – Leukemia, Sickle Cell
|Hartmut Land, Ph.D.
|The molecular basis of oncogene co-operation, cell cycle control and signal integration mechanisms
|Christopher W. Lawrence, Ph.D.
|DNA-damage resulting in mutagenesis
|Willis Li, Ph.D.
|Jane Liesveld, M.D.
|Growth factor regulation of bone marrow cells.Clinical trials for leukemia and non-Hodgkin’s lymphoma
|Marilyn N. Ling, M.D.
|Improve accuracy of radiation techniques / Image Segmentation; Brachytherapy
|Edith M. Lord, Ph.D.
|Immune responses which can control tumor development
|Sanjay Maggirwar, Ph.D.
|Lung inflammation and lung cancer
|Mahin D. Maines, Ph.D.
|Cell Cycle and Cell Signaling Pathways
|Lynne E. Maquat, Ph.D.
|Biochemistry / BiophysicsRNA metabolism in human disease, studies focused on RNA decay pathway
|Margot Mayer-Proschel, Ph.D.
|Biological and molecular mechanisms governing precursor cell division, differentiation and survival in the brain
|Carl McGary, M.D., Ph.D.
|The metastatic process
|Scott McIntosh, Ph.D.
|Self-help interventions for smoking cessation and behavioral change with various populations
|Edward Messing, M.D.
|Early detection, prevention, and treatment of urologic malignancies
|Craig Miller, M.D., Ph.D.
|Developing therapeutic strategies for treating cutaneous malignancies, specializing in cutaneous T-cell lymphomas
|L. Milner, M.D.
|Research Interests: Hematopoiesis and Stem Cell Biology
|Hiroshi Miyamoto, M.D., Ph.D.
|Cancer biologyProteins in prostate cancer
|Robert A. Mooney, Ph.D
|Dysregulation of tyrosine kinase receptors in type 2 diabetes and breast cancer
|Gary Morrow, Ph.D.
|Cancer control and clinical trials
|Tim Mosmann, Ph.D.
|Immune regulation by T-cell subsets and their cytokines
|Deborah Mulford, M.D.
|Clinical research in leukemia
|Karen Mustian, Ph.D.
|Cancer Therapeutic Control; Exercise and Sport Psychology/Physiology
|Mark Noble, Ph.D.
|Stem cell biologyEliminating cognitive impairment associated with the treatment of brain tumors
|Walter O’Dell, Ph.D.
|Heart Motion Modeling; MRI Motion Tracking
|Regis O’Keefe, M.D.
|Orthopaedic oncology (bone and soft tissue tumors)
|Paul Okunieff, M.D.
|Radiation oncology, specializing in urologic, gastrointestinal and neurologic cancers; supervisor of the Orange Service, which includes high dose brachytherapy, 3D treatment planning, and stereotactic radiosurgery; clinical protocols include an oligometastasis protocol for curative radiosurgical treatment of metastatic breast cancer; Translational Research Chair of the RTOG
|Deborah J. Ossip-Klein, Ph.D.
|Behavioral medicine; health impact of lifestyle changes with particular focus on cigarette smoking, obesity, aging, child/adolescent outcomes measurement, and community intervention
|James Palis, M.D.
|Breast, lung, gastrointestinal cancers and prevention
|Kevin J. Parker, Ph.D.
|Sonoelastography and detection of prostate cancer
|James Peacock, M.D.
|Alice P. Pentland, M.D.
|The role of phospholipases and cycloxgenases in epidermal function
|Gordon L. Phillips, M.D.
|Stem cell transplantation for leukemia, lymphoma and multiple myeloma
|Richard Phipps, Ph.D.
|Injury to the lung from exposure to chemotherapeutic agentsControl of malignant lymphoma cells and regulation of antibodyProducing lymphocytes by prostaglandins
|Robert H. Pierce
|Oxidative stress in tissue injury and neoplasia
|Colin Poulter, M.D.
|J. Edward Puzas, Ph.D.
|Molecular and cellular biology of the skeletal system
|Causes, treatment and prevention of bladder cancer
|Richard Reichman, M.D.
|Human Papillomavirus (HPV) and Human Immunodeficiency virus infections (HIV)
|Jacques Robert, Ph.D.
|Evolution of immune surveillance; thymocyte differentiation and thymic tumorigenesis
|Joe Roscoe, M.D.
|Design and analysis of research studies concerned with the therapeutic side effects of cancer treatment and patient quality of life
|Robert Rose, Ph.D.
|Human papillomavirus vaccines
|Randy Rosier, M.D., Ph.D.
|Regulation of endochondral ossification
|Deborah J. Rubens, M.D.
|3D Sonoelastography Imaging for Prostate Cancer
|Philip Rubin, M.D.
|Deepak Sahasrabudhe, M.D.
|Olle Jane Z. Sahler, M.D.
|Psychosocial adaptation to childhood cancer; complimentary medicine therapies
|Michael Schell, Ph.D.
|Dr. Schell has been responsible for introducing stereotactic radiosurgery, CT/MRI image correlation and 3D treatment planning
|Linda M. Schiffhauer, M.D.
|Protein expression in breast cancer
|Glynis Scott, M.D.
|Melanocyte biology and melanocyte tumors
|Benjamin Segal, M.D.
|Immune-central nervous system interactions: autoimmunity and tumor immunotherapy
|George B. Segel, M.D.
|Chronic leukemia; control of cell maturation
|Alan E. Senior, Ph.D.
|Preventing tumors from developing resistance to chemotherapy
|Abhay Ramchandra Shelke, M.D.
|Quality of life issues in cancer patients receiving both chemotherapy and radiotherapy
|Alice Sijts, Ph.D.
|Antigen processing by IFN-induced proteasomes and T-cell immunity
|Patricia Sime, M.D.
|Modulation of pulmonary inflammatory using gene transfer techniques
|Patricia J. Simpson-Haidaris, Ph.D.
|Breast and Lung Cancer
|Alan V. Smrcka, Ph.D.
|Molecular mechanisms of signal transductions
|Yin Sun, Ph.D.
|The process of tumor suppression
|Nancy Wang, Ph. D.
|Cancer cytogenetics; tumor suppression gene identification for human ovarian cancer
|Thomas Watson, M.D.
|Gene E. Watson II, D.D.S., M.S., Ph.D.
|Diagnosis, treatment and prevention of diseases of salivary glands and salivary gland hypofunction
|Jacqueline P. Williams, Ph.D.
|Radiation Biology; Late Effects
|Fay Young, M.D.
|How abnormal maturation of lymphocytes may lead to malignancies such as lymphoma.
|Sayeeda B. Zain, Ph.D.
|Tumor progression and metastases
|Jiyong Zhao, Ph.D.
|How cellular proliferation is regulated
|Jianhui Zhong, Ph.D.
|Molecular oncology and cancer biology